These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5736530)

  • 1. [Hepatic function and estrogenic therapy (TACE) in the climacteric].
    Cazzola D
    Riv Ostet Ginecol; 1968 Feb; 23(2):122-38. PubMed ID: 5736530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic changes in different hormone replacement therapies in climacteric].
    Foth D; Römer T; Panzig E
    Zentralbl Gynakol; 1995; 117(7):349-52. PubMed ID: 7668064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of chlorotrianisene (Tace) in the pre- and post-menopausal period].
    Pagnini P
    Minerva Ginecol; 1966 Feb; 18(4):168-74. PubMed ID: 5934707
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorotrianisene (TACE), a physiologic treatment for the climacteric.
    BRUMBAUGH JJ
    Antibiotic Med Clin Ther (New York); 1957 Mar; 4(3):179-82. PubMed ID: 13412073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern trends in substitutive estrogen therapy in the menopause: results of the use of chlorotrianisene].
    Bubani V; Sansa G
    Ann Ostet Ginecol Med Perinat; 1966 Oct; 88(10):755-84. PubMed ID: 5996069
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chlorotrianisene, a synthetic estrogen with prolonged action in the treatment of senile genital dystrophic states].
    Alfieri G
    Ann Ostet Ginecol Med Perinat; 1967 Mar; 89(3):200-9. PubMed ID: 5606696
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic considerations in the management of the climacteric. A critical analysis of prevalent treatments.
    Upton GV
    J Reprod Med; 1984 Feb; 29(2):71-80. PubMed ID: 6368816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy.
    Genazzani AR; Gambacciani M; Simoncini T; Schneider HP
    Climacteric; 2003 Sep; 6(3):188-203. PubMed ID: 14567767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogens and liver diseases].
    Osler M
    Ugeskr Laeger; 1974 Jan; 136(4):212. PubMed ID: 4822300
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.
    Aoki T; Imamura H; Hasegawa K; Matsukura A; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Arch Surg; 2004 Jul; 139(7):766-74. PubMed ID: 15249411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines].
    Chen XX; Zhang B; Zhang YQ; Hung GX; Chen MS; Guo RP; Lin XJ; Hu PL; Qiu HJ; Xu BP
    Ai Zheng; 2002 May; 21(5):547-9. PubMed ID: 12452052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Climacteric syndrome].
    Feldsher Akush; 1980; 45(4):55-8. PubMed ID: 6900000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychometric aspects of estrogen therapy in climacteric woman (study of 122 women after menopause].
    Wenderlein JM
    Z Klin Psychol Psychother; 1981; 29(3):263-7. PubMed ID: 6274104
    [No Abstract]   [Full Text] [Related]  

  • 18. [An update on the pharmacological therapy of the andropause].
    Fanghänel G; Yamamoto J; Sánchez-Reyes L; Zárate A
    Gac Med Mex; 2000; 136(2):175-81. PubMed ID: 10815331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormones for age related degeneration: meno-, andro-, somato-, adreno-: the end of pauses?].
    Füessl HS
    MMW Fortschr Med; 2007 Mar; 149(9):28-9. PubMed ID: 17612245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone therapy in climacteric. Varying research results on risks and benefits].
    Magnusson C; Persson I
    Lakartidningen; 1997 Mar; 94(13):1176-9. PubMed ID: 9148053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.